Suppr超能文献

Muc5AC在胃癌中的预后价值:一项荟萃分析。

Prognostic value of Muc5AC in gastric cancer: A meta-analysis.

作者信息

Zhang Chuan-Tao, He Ke-Cheng, Pan Fei, Li Yuan, Wu Jiang

机构信息

Chuan-Tao Zhang, Teaching Hospital of Chengdu University of Traditional Chinese Medicine and Sichuan Province Traditional Chinese Medicine Hospital, Chengdu 610041, Sichuan Province, China.

出版信息

World J Gastroenterol. 2015 Sep 28;21(36):10453-60. doi: 10.3748/wjg.v21.i36.10453.

Abstract

AIM

To assess the correlation between decreased Muc5AC expression and patients' survival and clinicopathological characteristics by conducting a meta-analysis.

METHODS

Literature searches were performed in PubMed and EMBASE, and 11 studies met our criteria. Summary hazard ratios or odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to estimate the effect. For the pooled analysis of the correlation between decreased Muc5AC expression and clinicopathological characteristics (tumour invasion depth, lymph node metastasis, tumour-node-metastasis stage, tumour size, venous invasion and lymphatic invasion), ORs and their variance were combined to estimate the effect.

RESULTS

Eleven retrospective cohort studies comprising 2135 patients were included to assess the association between Muc5AC expression and overall survival and/or clinicopathological characteristics. Decreased Muc5AC expression was significantly correlated with poor overall survival of gastric cancer patients (pooled HR = 1.35, 95%CI: 1.08-1.7). Moreover, decreased Muc5AC expression was also significantly associated with tumour invasion depth (pooled OR = 2.12, 95%CI: 1.56-2.87) and lymph node metastasis (pooled OR = 1.56, 95%CI: 1.00-2.44) in gastric cancer.

CONCLUSION

Decreased Muc5AC expression might be a poor prognostic predictor for gastric cancer.

摘要

目的

通过进行一项荟萃分析,评估黏蛋白5AC(Muc5AC)表达降低与患者生存率及临床病理特征之间的相关性。

方法

在PubMed和EMBASE中进行文献检索,11项研究符合我们的标准。计算汇总风险比或比值比(OR)及其95%置信区间(CI)以估计效应。对于Muc5AC表达降低与临床病理特征(肿瘤浸润深度、淋巴结转移、肿瘤-淋巴结-转移分期、肿瘤大小、静脉侵犯和淋巴侵犯)之间相关性的汇总分析,合并OR及其方差以估计效应。

结果

纳入11项回顾性队列研究,共2135例患者,以评估Muc5AC表达与总生存期和/或临床病理特征之间的关联。Muc5AC表达降低与胃癌患者较差的总生存期显著相关(汇总HR = 1.35,95%CI:1.08 - 1.7)。此外,Muc5AC表达降低在胃癌中也与肿瘤浸润深度(汇总OR = 2.12,95%CI:1.56 - 2.87)和淋巴结转移(汇总OR = 1.56,95%CI:1.00 - 2.44)显著相关。

结论

Muc5AC表达降低可能是胃癌预后不良的预测指标。

相似文献

1
Prognostic value of Muc5AC in gastric cancer: A meta-analysis.Muc5AC在胃癌中的预后价值:一项荟萃分析。
World J Gastroenterol. 2015 Sep 28;21(36):10453-60. doi: 10.3748/wjg.v21.i36.10453.

引用本文的文献

本文引用的文献

5
Histotype-based prognostic classification of gastric cancer.基于组织学分型的胃癌预后分类。
World J Gastroenterol. 2012 Mar 7;18(9):896-904. doi: 10.3748/wjg.v18.i9.896.
6
Novel immunotherapeutic strategies of gastric cancer treatment.胃癌治疗的新型免疫治疗策略。
J Biomed Biotechnol. 2011;2011:437348. doi: 10.1155/2011/437348. Epub 2011 Dec 27.
10
Global cancer statistics.全球癌症统计数据。
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验